A clinical study to check effect of two drugs bruhatlashunpinda and rasnasaptak kwatha on patients with manyastambha with special reference to cervical spondylosis.

Randomized controlled clinical study to evaluate efficacy of bruhatlashunpinda and rasnasaptak kwatha in the management of manyastambha with special reference to cervical spondylosis.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/08/044780

Enrollment

Registered

2022-08-22

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M471- Other spondylosis with myelopathy

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Well diagnosed patients of manyastambha (Cervical spondylosis). 2.Subjects having neck pain with or without radicular symptoms paresthesia since more than two months. 3.Cervical spondylitis confirmed by radiological assessment (X ray cervical vertebrae AP and lateral view. 4.Subjects were willing to give informed consent and ready to comply with the protocol. 5.Subjects who are ready to provide regular follow ups till completion of the study.

Exclusion criteria

Exclusion criteria: 1.Known cases of trauma of neck, local wound and infection over neck, cervical rib syndrome, any spinal cord disorders other than cervical spondylosis & myelopathy. 2.Known cases of shoulder and elbow musculoskeletal problems, fracture of spine and upper limb. 3.Known cases of inflammatory arthritis. 4.Subjects who use any other investigational drug within one month prior to randomization. 5.Known cases of Tuberculosis, HIV, Ischemic heart disease, Cancer. 6.Known cases of Hypertension, Hyperacidity, Peptic ulcer, Duodenal ulcer. 7.Pregnancy and Lactation. 8.Other conditions, which in the opinion of investigators, makes the patient unsuitable for enrollment or could interfere with his/her participation in, and completion of the protocol.

Design outcomes

Primary

Measure	Time frame
Improvement in Visual Analog Scale, Neck Disability Index, Goniometry readings and neck pain, stiffness, restricted neck movements.Timepoint: 4 weeks	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Neena Damle

D. Y. Patil school of Ayurveda

prachidk10@gmail.com9028191514

Outcome results